Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
13,672,126
-
Share change
-
+1,169,225
-
Total reported value
-
$43,069,128
-
Put/Call ratio
-
213%
-
Price per share
-
$3.15
-
Number of holders
-
64
-
Value change
-
+$3,840,417
-
Number of buys
-
28
-
Number of sells
-
34
Institutional Holders of ACELRX PHARMACEUTICALS INC - COM (ACRX) as of Q1 2017
As of 31 Mar 2017 ACELRX PHARMACEUTICALS INC - COM (ACRX) had 64 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 13,672,126 shares of stock of the company.
Largest 10 holders included PERCEPTIVE ADVISORS LLC, BlackRock Inc., VANGUARD GROUP INC, Palo Alto Investors, LLC, STATE STREET CORP, NORTHERN TRUST CORP, DEUTSCHE BANK AG\, BRIDGEWAY CAPITAL MANAGEMENT INC, GEODE CAPITAL MANAGEMENT, LLC, and WealthTrust Axiom LLC.
This table shows 64 institutional shareholders of the security as of 31 Mar 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.